Literature DB >> 9250893

Disorder of bile acid metabolism in children with short bowel syndrome.

N Ohkohchi1, T Andoh, U Izumi, Y Igarashi, R Ohi.   

Abstract

The profile of fecal bile acids was examined in 13 children with short bowel syndrome; 7 of the 13 did not have diarrhea and the other 6 had intractable diarrhea. In children without diarrhea, no severe fat malabsorption was recognized, and the content of total bile acids in the feces was within the normal range or slightly higher. The ratio of primary to total bile acids showed various patterns. In children with intractable diarrhea, in contrast, fat malabsorption was observed and the fecal content of total bile acids in these patients was more than ten times higher than that of the control group, primary bile acids accounting for more than 95% of the total bile acids and taurine- or glycine-conjugated bile acids for 10%. In the children with intractable diarrhea, the values for the D-xylose absorption test were lower than the normal range. These results suggested that, in children with short bowel syndrome with diarrhea, the loss of bile acids was strongly associated with a decrease in the actual absorptive surface area of the residual small intestine, and the growth of the normal bacterial flora was disturbed in the residual intestine. Some children with or without diarrhea also had hyper bile acidemia. Ursodeoxycholic acid was not effective for the treatment of hyper bile acidemia or fat malabsorption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250893     DOI: 10.1007/bf02934085

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  26 in total

1.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

3.  [Analysis of free, glycine-and taurine-conjugated individual bile acids using high performance liquid chromatography and immobilized 3 alpha-hydroxysteroid dehydrogenase in column form (author's transl)].

Authors:  S Okuyama
Journal:  Rinsho Byori       Date:  1981-05

4.  Micellar solubilization of intestinal lipids after ursodeoxycholic acid therapy in short bowel patients and healthy controls.

Authors:  A W Huijbregts; T M Cox; J Hermsen; G P van Berge Henegouwen; A van Schaik; V S Chadwick
Journal:  Neth J Med       Date:  1981       Impact factor: 1.422

5.  Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.

Authors:  A Stiehl; R Raedsch; G Rudolph
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  Bile acid-induced diarrhoea.

Authors:  H Fromm; M Malavolti
Journal:  Clin Gastroenterol       Date:  1986-07

7.  Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.

Authors:  K Nilsell; B Angelin; B Leijd; K Einarsson
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

8.  Fecal and biliary bile acid patterns in children with bile acid malabsorption.

Authors:  Y Tazawa; M Yamada; M Nakagawa; H Suzuki; Y Igarashi; T Konno; K Tada
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-06       Impact factor: 2.839

9.  Characterization of trisubstituted cholanoic acids in human feces.

Authors:  P Eneroth; B Gordon; J Sjövall
Journal:  J Lipid Res       Date:  1966-07       Impact factor: 5.922

10.  Identification of mono- and dihydroxy bile acids in human feces by gas-liquid chromatography and mass spectrometry.

Authors:  P Eneroth; B Gordon; R Ryhage; J Sjövall
Journal:  J Lipid Res       Date:  1966-07       Impact factor: 5.922

View more
  4 in total

1.  Use of a novel docosahexaenoic acid formulation vs control in a neonatal porcine model of short bowel syndrome leads to greater intestinal absorption and higher systemic levels of DHA.

Authors:  Camilia R Martin; Barbara Stoll; Joanne Cluette-Brown; Adesola C Akinkuotu; Oluyinka O Olutoye; Kathleen M Gura; Pratibha Singh; Munir M Zaman; Michael C Perillo; Mark Puder; Steven D Freedman; Doug Burrin
Journal:  Nutr Res       Date:  2017-02-04       Impact factor: 3.315

Review 2.  Bile Acid Diarrhea in Adults and Adolescents.

Authors:  Michael Camilleri; Samuel Nurko
Journal:  Neurogastroenterol Motil       Date:  2021-11-09       Impact factor: 3.598

Review 3.  Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota.

Authors:  Monika Cahova; Miriam Bratova; Petr Wohl
Journal:  Nutrients       Date:  2017-09-07       Impact factor: 5.717

4.  Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.

Authors:  Sorena Afshar; Fiona Malcomson; Seamus B Kelly; Keith Seymour; Sean Woodcock; John C Mathers
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.